Nautilus Biotechnology, Inc. (NAUT) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $34.14M | +0.4% |
| 2024 | $34.01M | -15.4% |
| 2023 | $40.21M | +14.5% |
| 2022 | $35.13M | +0.7% |
| 2021 | $34.87M | +452.3% |
| 2020 | $6.31M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $34.14M | +0.4% |
| 2024 | $34.01M | -15.4% |
| 2023 | $40.21M | +14.5% |
| 2022 | $35.13M | +0.7% |
| 2021 | $34.87M | +452.3% |
| 2020 | $6.31M | — |